CDKN2A and neoplasm: Collectively, CDKN2A interacts with several genes to regulate the cell cycle and division, and the epigenetic or genetic alterations to CDKN2A would have several impacts including unregulated cell division, manipulation of several immune components that finally stimulate tumor progression, and these factors lastly would enable a poor clinical outcome.